Adcon C

Drug Profile

Adcon C

Alternative Names: Adcon-C

Latest Information Update: 22 Dec 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gliatech (CEASED)
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Post-surgical adhesions

Most Recent Events

  • 22 Dec 2003 Discontinued - Preclinical for Post-surgical adhesions in USA (Topical)
  • 26 Sep 2002 Gliatech is auctioning its Adcon® assets
  • 17 May 2002 Gliatech has filed a petition for bankruptcy protection
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top